References
- RubinDCShakerALevinMSChronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancerFront Immunol2012310722586430
- MowatCColeAWindsorAGuidelines for the management of inflammatory bowel disease in adultsGut20116057160721464096
- FarrellDMcCarthyGSavageESelf-reported symptom burden in individuals with inflammatory bowel diseaseJ Crohns Colitis20161031532226598526
- LiveraniEScaioliEDigbyRJHow to predict clinical relapse in inflammatory bowel disease patientsWorld J Gastroenterol2016221017103326811644
- FoundationCDHBest practices in IBD care. Taking steps to introduce an integrated multidisciplinary patient-centric care model2013 Available from: http://www.cdhf.ca/bank/document_en/75best-practices-in-ibd-care.pdfAccessed July 6, 2016
- SohrabpourAAMalekzadehRKeshavarzianACurrent therapeutic approaches in inflammatory bowel diseaseCurr Pharm Des2010163668368321128898
- BurgerDTravisSConventional medical management of inflammatory bowel diseaseGastroenterology20111401827.e21837.e221530749
- AmiotAPeyrin-BirouletLCurrent, new and future biological agents on the horizon for the treatment of inflammatory bowel diseasesTherap Adv Gastroenterol201586682
- SiegelCAMaking therapeutic decisions in inflammatory bowel disease: the role of patientsCurr Opin Gastroenterol20092533433819417646
- SiegelCALost in translation: helping patients understand the risks of inflammatory bowel disease therapyInflamm Bowel Dis2010162168217220848508
- SiegelCAShared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment optionsGut20126145946522187072
- ShahSLSiegelCAIncreasing patient activation could improve out-comes for patients with inflammatory bowel diseaseInflamm Bowel Dis2015212975297826422517
- TriantafillidisJKMerikasEGeorgopoulosFCurrent and emerging drugs for the treatment of inflammatory bowel diseaseDrug Des Devel Ther20115185210
- JohnsonFRHauberBOzdemirSAre gastroenterologists less tolerant of treatment risks than patients? Benefit-risk preferences in Crohn’s disease managementJ Manag Care Pharm20101661662820866166
- GonzalezJWilliamsJWJrNoelPHAdherence to mental health treatment in a primary care clinicJ Am Board Fam Pract200518879615798137
- VlasnikJJAliottaSLDeLorBMedication adherence: factors influencing compliance with prescribed medication plansCase Manager2005164751
- Sawtooth Software Inc2013Technical Paper SeriesThe CBC system for choice-based conjoint analysis (version 8) Available from: https://www.sawtoothsoftware.com/download/techpap/cbctech.pdfAccessed July 11, 2017
- National Institute for Health and Care Excellence: Guidance. National Clinical Guideline CentreUlcerative colitis: management in adults, children and young peopleLondonRoyal College of Physicians (UK)2013
- JohnsonFROzdemirSMansfieldCCrohn’s disease patients’ risk-benefit preferences: serious adverse event risks versus treatment efficacyGastroenterology200713376977917628557
- GrayJRLeungEScalesJTreatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapyAliment Pharmacol Ther2009291114112019222412
- LichtensteinGRWatersHCKellyJAssessing drug treatment preferences of patients with crohn’s disease: a conjoint analysisPatient20103113123
- SylwestrzakGLiuJStephensonJJConsidering patient preferences when selecting anti-tumor necrosis factor therapeutic optionsAm Health Drug Benefits20147718124991392
- AllenPBLindsayHThamTCHow do patients with inflammatory bowel disease want their biological therapy administered?BMC Gastroenterol201010120064220
- BewtraMFairchildAOGilroyEInflammatory bowel disease patients’ willingness to accept medication risk to avoid future disease relapseAm J Gastroenterol20151101675168126482859
- SichtmannCWilkenRDiamantopoulosAEstimating willingness-to-pay with choice-based conjoint analysis – can consumer characteristics explain variations in accuracy?Br J Management201122628645
- BaarsJEMarkusTKuipersEJPatients’ preferences regarding shared decision-making in the treatment of inflammatory bowel disease: results from a patient-empowerment studyDigestion20108111311920093836
- DignassALindsayJOSturmASecond European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current managementJ Crohns Colitis20126991103023040451
- DignassAVan AsscheGLindsayJOThe second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current managementJ Crohns Colitis20104286221122489
- GomollonFDignassAAnneseV3rd EUROPEAN Evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical managementJ Crohns Colitis20171132527660341